Pubblicazioni Scientifiche
Dermatologia02 dic 2020
Prurigo nodularis
Pathogenesis and management
02 dic 2020
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years
In this cohort study of 129 patients with vulvar melanosis and 5 to 20 years of follow-up, 67% of vulvar melanotic lesions appeared in premenopausal patients, and 65% of all patients had received some type of hormone therapy;
24 nov 2020
Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic
Risk Analysis from the PSO-BIO-COVID Observational Study
24 nov 2020
Autoimmunity in Segmental Vitiligo
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized.
24 nov 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
Atopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities.
17 nov 2020
DIAGNOSTIC ACCURACY OF DERMOSCOPY OF ACTINIC KERATOSIS: A SYSTEMATIC REVIEW
Dermoscopy is a tool that aids clinicians in the diagnosis of actinic keratosis;
17 nov 2020
Cutaneous Melanoma Arising in Congenital Melanocytic Nevus
A Retrospective Observational Study
17 nov 2020
5‐Alpha‐Reductase Inhibitors are Associated with Reduced Frequency of COVID‐19 Symptoms in Males with Androgenetic Alopecia
We have previously reported that men with androgenetic alopecia (AGA) are more likely to present with severe COVID‐19 symptoms, potentially implicating androgen sensitivity as a risk factor for COVID‐19.
11 nov 2020
Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis
Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one‐year observational cohort study of the first 100 patients treated
11 nov 2020
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma
03 nov 2020
Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis
Biologics are modern immunomodulatory drugs, whose use in the treatment of psoriasis has led to remarkable results in psoriatic patients. The administration of these agents in special population groups, such as patients with chronic infections and renal impairment, as well as perioperative, pregnant or lactating patients, has not been thoroughly addressed, mostly because these patients are excluded from clinical studies.
03 nov 2020
Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions
Current guidelines recommend local excision margin (EM) with 1 to 2 cm on primary Merkel cell carcinoma (MCC) sites.
03 nov 2020
Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial
Guidelines for photodynamic therapy (PDT) of actinic keratosis (AK) recommend pretreatment with curettage. The impact of curettage on cure rate is, however, not well established.
29 ott 2020
Cutaneous adverse reactions to anti–PD-1 treatment. A systematic review
A systematic review
29 ott 2020
Expanding treatment options for rosacea
Such a high-quality cluster randomized controlled trial involving 2040 nurses across the UK.
29 ott 2020
Dermoscopy of genital diseases: a review
A review
20 ott 2020
Immunogenicity of biologic therapies in psoriasis Myths, facts and a suggested approach
With biologic drugs dominating the therapeutic space for severe immune‐mediated inflammatory disease, it is critical for clinicians to be familiar with the concept of drug immunogenicity, with the potential for our patients to develop anti‐drug antibodies (ADA) of clinical relevance.
20 ott 2020
Long‐term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients
Dupilumab, an inhibitor of interleukin (IL)‐4/13 activity, is a biological agent approved for the treatment of moderate‐to‐severe atopic dermatitis (AD)
20 ott 2020
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis
Is exposure to topical calcineurin inhibitors among adult patients with atopic dermatitis associated with increased keratinocyte carcinoma risk?
11 ott 2020
No increased risk of melanoma among patients with psoriasis treated with methotrexate
Patients with an impaired immune system have higher risk for melanoma, the most dangerous type of skin cancer, and a worse prognosis.